corner
Healthy Skepticism
Join us to help reduce harm from misleading health information.
Increase font size   Decrease font size   Print-friendly view   Print
Register Log in

Healthy Skepticism Library item: 3128

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

 

Publication type: Journal Article

Budiansky S.
Drug promotion: FDA steps in
Nature 1982 Aug 26; 298:784-785


Abstract:

The Food and Drug Administration has issued a list of recommendations to deal with the problem of preapproval promotion of new drugs. The agency said that it will object to any advertisement that makes claims of safety and efficacy even if the new drug is not specified. On-the-other hand, if the name is specified advertising copy may not suggest the drug’s indications, uses, safety or effectiveness, nor may any other advertisements or even the graphics that appear. Another loophole that concerns the FDA is preapproval promotion of drugs at scientific meetings.

Keywords:
*news story/United States/Food and Drug Administration/FDA/regulation of promotion/new drugs/preapproval promotion/PROMOTIONAL TECHNIQUES: PREAPPROVAL PROMOTION/REGULATION, CODES, GUIDELINES: DIRECT GOVERNMENT REGULATION Advertising* Drug Industry* United States United States Food and Drug Administration

 

  Healthy Skepticism on RSS   Healthy Skepticism on Facebook   Healthy Skepticism on Twitter

Please
Click to Register

(read more)

then
Click to Log in
for free access to more features of this website.

Forgot your username or password?

You are invited to
apply for membership
of Healthy Skepticism,
if you support our aims.

Pay a subscription

Support our work with a donation

Buy Healthy Skepticism T Shirts


If there is something you don't like, please tell us. If you like our work, please tell others.

Email a Friend








...to influence multinational corporations effectively, the efforts of governments will have to be complemented by others, notably the many voluntary organisations that have shown they can effectively represent society’s public-health interests…
A small group known as Healthy Skepticism; formerly the Medical Lobby for Appropriate Marketing) has consistently and insistently drawn the attention of producers to promotional malpractice, calling for (and often securing) correction. These organisations [Healthy Skepticism, Médecins Sans Frontières and Health Action International] are small, but they are capable; they bear malice towards no one, and they are inscrutably honest. If industry is indeed persuaded to face up to its social responsibilities in the coming years it may well be because of these associations and others like them.
- Dukes MN. Accountability of the pharmaceutical industry. Lancet. 2002 Nov 23; 360(9346)1682-4.